Treatment News : Post-Cure Hep C Reinfection Is Common Among Prisoners

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 22, 2013

Post-Cure Hep C Reinfection Is Common Among Prisoners

Prisoners who achieve a cure for hepatitis C virus (HCV) are at high risk for reinfection, especially if they continue to inject drugs on the inside. Reporting their findings in the journal Hepatology, researchers studied 119 prisoners who had achieved a sustained virologic response (SVR, considered a cure) following treatment for hep C.

The study population was 98 percent male, with a median age of 33, and 81 percent of them had a history of injection drug use (IDU). Following a median follow-up period of 1.4 years, nine of the participants were reinfected with hep C, with seven of them switching virus genotypes, for an overall reinfection rate of 5.27 cases per 100 person-years. The incidence of reinfection was 12.47 times higher among those actively using drugs compared with those not using post-treatment, 9.95 times higher among those coinfected with HIV compared with HIV-negative participants, and 7.47 times higher among those engaging in more than one risk behavior following treatment compared with those engaging in either one or no risk behaviors.

The investigators stresssed that “preventative interventions at diagnosis and during and after HCV treatment should be strongly reinforced.”

To read the study abstract, click here.

Search: hepatitis C virus, HCV, hep C, reinfection, prisoners, cure, Hepatology, injection drug use, HIV, coinfection.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.